How to Help Your Patients Save Money on Twynsta: A Provider's Guide to Savings Programs

Generic telmisartan/amlodipine (formerly sold as brand-name Twynsta) can cost $120–$480 per month at retail — a significant barrier to adherence. Hypertension requires consistent medication; patients who can't afford their prescriptions simply stop taking them, increasing cardiovascular risk. This guide equips clinicians with practical, evidence-based strategies to reduce medication costs for their patients.

Understanding the Cost Landscape

The brand-name Twynsta has been discontinued by Boehringer Ingelheim. The generic telmisartan/amlodipine is available but produced by only a small number of manufacturers. As a result:

Average retail price for a 30-day supply: approximately $472–$480

With GoodRx or similar discount card: as low as $123/month

Generic amlodipine + generic telmisartan as separate prescriptions: approximately $18–$40/month combined

This three-fold variation creates significant opportunity for cost reduction with the right prescribing strategy.

Strategy #1: Prescribe the Components Separately (Highest Impact)

The highest-impact cost intervention is also the simplest: write two separate prescriptions for generic amlodipine and generic telmisartan. Both are Tier 1 generics on virtually all formularies, widely available at every pharmacy, and carry no prior authorization requirements.

Patient savings potential: $80–$440 per month compared to the combination tablet at retail, or $80–$100 compared to a discount-card price. For a patient on a fixed income, this savings is often the difference between adherence and non-adherence.

When counseling patients on this switch: "I'm prescribing the same two medications that were in Twynsta as separate pills. You'll take one amlodipine and one telmisartan every day — the exact same treatment, just two pills. This will cost significantly less."

Strategy #2: Review Insurance Tier Placement

The generic combination telmisartan/amlodipine is typically placed on Tier 2–3 of formularies. In contrast:

Generic amlodipine: Tier 1 on virtually all plans ($0–$10 copay)

Generic telmisartan: Tier 1–2 on most plans ($0–$25 copay), often with Medicare Part D as well

Prescribing separately frequently results in substantially lower copays. During any patient conversation about medication costs, consider asking: "Has your pharmacist told you what your copay is for each component separately versus the combination?"

Strategy #3: Leverage Discount Cards for Combination Pill Patients

For patients who strongly prefer the single-tablet combination and cannot switch, discount cards offer meaningful savings:

GoodRx: As low as $123/month (74% off retail). Recommend patients visit goodrx.com and compare prices before each fill, as the cheapest pharmacy changes.

SingleCare, RxSaver, Optum Perks: Additional options to compare. $20–$50 variation in price is common between discount platforms for the same drug at the same pharmacy.

Cost Plus Drugs (costplusdrugs.com): Mark Cuban's transparent pricing pharmacy. Offers competitive prices on generic telmisartan and amlodipine individually with home delivery. Particularly useful for the separate-prescription approach.

Strategy #4: Patient Assistance Programs for Uninsured or Underinsured Patients

For patients without insurance or with very high out-of-pocket costs, these programs provide access to medications at reduced or no cost:

Boehringer Ingelheim Cares Foundation: Provides assistance for qualifying uninsured patients needing BI-manufactured medications. Application available at boehringer-ingelheim.com.

NeedyMeds (needymeds.org): Comprehensive database of PAPs and disease-based assistance programs. Useful for social workers and care coordinators helping with applications.

RxAssist (rxassist.org) and RxHope (rxhope.com): Searchable directories for manufacturer PAPs covering antihypertensives.

Medicaid and CHIP: For patients who may qualify, enrollment in Medicaid often covers generic blood pressure medications at no or minimal cost.

Strategy #5: 90-Day Supply via Mail Order

For stable patients, a 90-day supply via mail-order pharmacy is consistently more cost-effective than monthly retail fills — typically 2x the cost of a 30-day supply (a 33% per-pill savings). Most insurance plans offer this through their contracted mail-order partner. Writing a 90-day prescription with 3 refills is appropriate for patients who are stable on their current dose.

When Patients Can't Find the Medication at All

For patients who are stable on the combination tablet and want to continue it rather than switch, pharmacy availability is an additional barrier. medfinder can help — it contacts pharmacies near the patient to identify which ones have the medication in stock. Recommending this service to patients who call about fill difficulties can save staff time handling those calls.

Building This Into Your Practice Workflow

Consider adding a standard discussion about medication cost to annual medication reconciliation visits, especially for patients on combination antihypertensives like telmisartan/amlodipine. For additional clinical guidance on helping patients navigate availability challenges, see our companion guide: How to help patients find Twynsta in stock: a provider's guide.